Denosumab
- Biologic
- Prolia
Therapy management checklist
Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.
Loading the therapy management checklist…
Storage and cold chain
Denosumab: storage and handling
- Refrigerate
- Yes, as the label states
Label statement
Store Prolia refrigerated at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light.
- Freezing
- Do not freeze
Label statement
Do not freeze.
- Room temperature
- at or below 25°C (77°F)
Label statement
Prior to administration, Prolia may be allowed to reach room temperature up to 25°C (77°F) in the original container.
- Room temperature
- up to 30 days at or below 25°C (77°F)
Label statement
Once removed from the refrigerator, Prolia must not be exposed to temperatures above 25°C (77°F) and must be used within 30 days.
- Back into the refrigerator
- Not addressed
- Light
- Protect from light
Label statement
Store Prolia refrigerated at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light.
- Shaking
- Do not shake
Label statement
Avoid vigorous shaking of Prolia.
All storage statements on the label (7)
- Store Prolia refrigerated at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light.
- Do not freeze.
- Prior to administration, Prolia may be allowed to reach room temperature up to 25°C (77°F) in the original container.
- Once removed from the refrigerator, Prolia must not be exposed to temperatures above 25°C (77°F) and must be used within 30 days.
- Discard Prolia if not used within the 30 days.
- Protect Prolia from direct light and heat.
- Avoid vigorous shaking of Prolia.
FDA label version 186, effective June 26, 2026. DailyMed
Dosing and titration calendar
Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.
Loading dosing schedules…
Biosimilars
Xgeva: 20 licensed biosimilar products, 20 interchangeable (FDA Purple Book). Compare presentations and dates
Medicare Part D coverage
5,496 Part D plans, CMS formulary files 2026Q3. Look up tier, PA, step therapy and quantity limits by plan
Patient assistance
No manufacturer program page is listed for this drug yet.
Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.
For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.